Article
Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Experimental and molecular pathology - 1 Feb 2015
Ananda Guruprasad, Mockus Susan, Lundquist Micaela, Spotlow Vanessa, Simons Al, Mitchell Talia, Stafford Grace, Philip Vivek, Stearns Timothy, Srivastava Anuj, Barter Mary, Rowe Lucy, Malcolm Joan, Bult Carol, Karuturi Radha Krishna Murthy, Rasmussen Karen, Hinerfeld Douglas
Abstract excerpt
BACKGROUND: The continued development of targeted therapeutics for cancer treatment has required the concomitant development of more expansive methods for the molecular profiling of the patient's tumor. We describe the validation of the JAX Cancer Treatment Profile™ (JAX-CTP™), a next generation sequencing (NGS)-based molecular diagnostic assay that detects actionable mutations in solid tumors to inform the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
